
Product Description
SPECIFICATION
Generics
Empagliflozin + Linagliptin
Used For
Diabetes
Indication
Empagliflozin + Linagliptin are indicated as an adjunct to diet and exercise in adults aged 18 years and older with type 2 diabetes mellitu s: to improve glycemic control when metformin and/or sulphonylurea (SU) and monotherapy of either of Empagliflozin and Linagliptin do not provide adequate glycemic control. – when already being treated with the free combination of Empagliflozin and Linagliptin. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Related products
ZAFNOL 50MG TAB
₨ 5 / per unit
-4%
₨ 5,500 Original price was: ₨ 5,500. / per unit




